Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02430818 · ClinicalTrials.gov registry record · NA

Comparing Ketamine and Morphine in the Treatment of Acute Fracture Pain

A NA study, sponsored by Washington University School of Medicine.

Terminated
Registry status
NA
Development phase
13
Enrollment target

NCT02430818 is a NA study that was terminated before completion, run by Washington University School of Medicine. The registered enrollment target is 13 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02430818, a NA study, was terminated before completion, sponsored by Washington University School of Medicine.

TERMINATED
Registry status
NA
Development phase
13 participants
Enrollment target

Study Summary

Opioid pain medications such as morphine and dilaudid are commonly used in emergency departments to treat pain in patients. Physicians are familiar with the side effects of these medications; the most concerning of which is slowing or stopping a patient's breathing, as well as dangerously lowering their blood pressure. An alternative medication is ketamine. This medication is also commonly used in the emergency department, although it is typically used to help sedate patients for uncomfortable procedures. Ketamine has also been used for pain control, but in a much lower dosage that does not sedate patients. When used for analgesia, it has typically been administered in combination with opioid pain medications. To date, there is no study that looks at the effectiveness and safety of using a low dose ketamine alone in comparison to the use of morphine. The purpose of this study is to measure how well low-dose ketamine treats pain compared to morphine and to look at how often serious side effects are seen with each medication.

Interventions

  • DRUG ketamine
  • DRUG morphine

Trial Details

FieldValue
Enrollment Target 13 participants
Start Date 2015-04
Est. Completion 2017-09
Phase NA

What the Registry Record Tells You About NCT02430818

The ClinicalTrials.gov registry entry for NCT02430818 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 13 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which ketamine is the first listed.

NCT02430818 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02430818 about?

NCT02430818 is a clinical study titled "Comparing Ketamine and Morphine in the Treatment of Acute Fracture Pain". Opioid pain medications such as morphine and dilaudid are commonly used in emergency departments to treat pain in patients. Physicians are familiar with the side effects of these medications; the most concerning of which is slowing or stopping a patient's breathing, as well as dangerously lowering t...

What is the current status of trial NCT02430818?

This trial is currently terminated. It is a NA study. The enrollment target is 13 participants. The study started on 2015-04. Estimated completion is 2017-09.

What interventions are being tested in trial NCT02430818?

The interventions under investigation include: ketamine (DRUG), morphine (DRUG).

Who is sponsoring clinical trial NCT02430818?

This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.